ORACLE INVESTMENT MANAGEMENT INC Hedge Fund

CIK: 0001012622 · Show all filings

Period: Q1 2016 (← Previous) (Next →)

Filing Date: Aug 15, 2016

Total Value ($000): $384,577 (100.0% shares, 0.0% debt)

Holdings (20)

— ACCELERATE DIAGNOSTICS INC 18.8%

Value ($000) $72,392 Shares 5,037,747 Est. Cost $24998.12 Unrealized —

— QUIDEL CORP 11.6%

Value ($000) $44,420 Shares 2,573,554 Est. Cost $25530.00 Unrealized —

OPK OPKO HEALTH INC 10.6%

Value ($000) $40,666 Shares 3,914,000 Est. Cost $6.96 Unrealized +31.2%

— NXSTAGE MEDICAL INC 10.5%

Value ($000) $40,393 Shares 2,694,636 Est. Cost $13115.35 Unrealized —

— MAZOR ROBOTICS LTD 9.4%

Value ($000) $36,195 Shares 2,909,566 Est. Cost $11234.47 Unrealized —

— TESARO INC 7.3%

Value ($000) $28,222 Shares 640,966 Est. Cost $24845.03 Unrealized —

PACB PACIFIC BIOSCIENCES CALIF IN 6.9%

Value ($000) $26,610 Shares 3,312,089 Est. Cost $4.10 Unrealized +139.8%

ARAY ACCURAY INC 3.8%

Value ($000) $14,758 Shares 2,553,218 Est. Cost $5.71 Unrealized -3.0%

— BIOLASE INC 3.6%

Value ($000) $13,794 Shares 10,529,525 Est. Cost $1522.78 Unrealized —

— INTREXON CORP 3.6%

Value ($000) $13,682 Shares 403,729 Est. Cost $8662.39 Unrealized —

— VERMILLION INC 3.3%

Value ($000) $12,678 Shares 8,624,225 Est. Cost $1646.88 Unrealized —

— Hansen Medical 3.0%

Value ($000) $11,702 Shares 4,491,820 Est. Cost $722.69 Unrealized —

— AMARIN CORP PLC 2.3%

Value ($000) $8,903 Shares 5,818,805 Est. Cost $947.16 Unrealized —

— AGENUS INC 2.0%

Value ($000) $7,831 Shares 1,882,477 Est. Cost $1053.96 Unrealized —

— TRANSITION THERAPEUTICS INC 1.3%

Value ($000) $4,887 Shares 3,817,972 Est. Cost $3769.73 Unrealized —

— CONTRAFECT CORP 1.0%

Value ($000) $4,019 Shares 1,182,032 Est. Cost $5.25 Unrealized —

BIIB BIOGEN INC 0.5%

Value ($000) $1,750 Shares 6,723 Est. Cost $213.68 Unrealized +23.6%

— METABOLIX Inc 0.4%

Value ($000) $1,381 Shares 726,935 Est. Cost $294.87 Unrealized —

— SECOND SIGHT MED PRODS INC 0.1%

Value ($000) $245 Shares 50,804 Est. Cost $10.26 Unrealized —

— ZIOPHARM ONCOLOGY INC 0.0%

Value ($000) $49 Shares 6,661 Est. Cost $12.00 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ACCELERATE DIAGNOSTICS INC	5,037,747	$72,392	18.8%	$24998.12	—	COM	004304200
—	QUIDEL CORP	2,573,554	$44,420	11.6%	$25530.00	—	COM	74838J101
OPK	OPKO HEALTH INC	3,914,000	$40,666	10.6%	$6.96	+31.2%	COM	68375N103
—	NXSTAGE MEDICAL INC	2,694,636	$40,393	10.5%	$13115.35	—	COM	67072V103
—	MAZOR ROBOTICS LTD	2,909,566	$36,195	9.4%	$11234.47	—	SPONSORED ADS	57886P103
—	TESARO INC	640,966	$28,222	7.3%	$24845.03	—	COM	881569107
PACB	PACIFIC BIOSCIENCES CALIF IN	3,312,089	$26,610	6.9%	$4.10	+139.8%	COM	69404D108
ARAY	ACCURAY INC	2,553,218	$14,758	3.8%	$5.71	-3.0%	COM	004397105
—	BIOLASE INC	10,529,525	$13,794	3.6%	$1522.78	—	COM	090911108
—	INTREXON CORP	403,729	$13,682	3.6%	$8662.39	—	COM	46122T102
—	VERMILLION INC	8,624,225	$12,678	3.3%	$1646.88	—	COM NEW	92407M206
—	Hansen Medical	4,491,820	$11,702	3.0%	$722.69	—	COM	411307101
—	AMARIN CORP PLC	5,818,805	$8,903	2.3%	$947.16	—	SPONS ADR NEW	023111206
—	AGENUS INC	1,882,477	$7,831	2.0%	$1053.96	—	COM	00847G101
—	TRANSITION THERAPEUTICS INC	3,817,972	$4,887	1.3%	$3769.73	—	COM NEW	893716209
—	CONTRAFECT CORP	1,182,032	$4,019	1.0%	$5.25	—	COM	212326102
BIIB	BIOGEN INC	6,723	$1,750	0.5%	$213.68	+23.6%	COM	09062X103
—	METABOLIX Inc	726,935	$1,381	0.4%	$294.87	—	COM	591018809
—	SECOND SIGHT MED PRODS INC	50,804	$245	0.1%	$10.26	—	COM	81362J100
—	ZIOPHARM ONCOLOGY INC	6,661	$49	0.0%	$12.00	—	COM	98973P101